ADLER, REID, G.
88
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie71
Organische Feinchemie6
Medizinische Technologie1

Heimatländer der Klienten

Zusammenfassung

ADLER, Reid, G. ist besonders erfahren in den Technologien „Biotechnologie“ und „Organische Feinchemie“. 85% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „YALE UNIVERSITY“ und „COR THERAPEUTICS, INC.“. Besonders viele Patentanmeldungen wurden in den Jahren 1999 und 1998 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

1
Patentanmeldungen
75
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1YALE UNIVERSITYUSA25
2COR THERAPEUTICS, INC.USA15
3MAGAININ PHARMACEUTICALS INC.USA10
4LUDWIG INSTITUTE FOR CANCER RESEARCHTürkei4
5THE RESEARCH AND DEVELOPMENT INSTITUTE, INC.USA4
6GENE LOGIC, INC.USA3
7THE BOARD OF REGENTS OF THE UNIVERSITY AND COMMUNITY COLLEGE SYSTEM OF NEVADA ON BEHALF OF THE UNIVERSITY OF NEVADA-RENOUSA3
8THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATIONUSA3
9LIGOCYTE PHARMACEUTICALS, INC.USA2
10CARY MEDICAL CORPORATIONUSA1
11GEORGETOWN UNIVERSITY MEDICAL CENTERUSA1
12KRISHNAMURTHY, RAJESHUSA1
13MONTANA STATE UNIVERSITY-BOZEMANKorea, Rep.1
14NAGY, JON, O.Korea, Rep.1
15NATIONAL INSTITUTES OF HEALTHUSA1
16OTOGEN CORPORATIONUSA1
17OTRACES INC.USA1
18QUIDEL CORPORATIONUSA1
19TERRAPIN TECHNOLOGIES, INC.USA1
20THE HENRY M. JACKSON FOUNDATIONUSA1
21THE REGENTS OF THE UNIVERSITY OF MICHIGANUSA1
22UNIVERSITY OF CALIFORNIAIndien1
23UNIVERSITY OF HAWAIIUSA1
24UNIVERSITY OF WASHINGTONUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2014193481RAPID MICROBIAL DETECTIONKRISHNAMURTHY, RAJESH
2014
WO2014158287A METHOD FOR IMPROVING DISEASE DIAGNOSIS USING MEASURED ANALYTESOTRACES INC.
2014
WO2002100325POLYVALENT NANOPARTICLESNAGY, JON, O.
LIGOCYTE PHARMACEUTICALS, INC.
MONTANA STATE UNIVERSITY-BOZEMAN
2002
WO2001081375DNA & PROTEIN BINDING MINIATURE PROTEINSYALE UNIVERSITY
2001
WO2001049867M CELL DIRECTED VACCINESTHE RESEARCH AND DEVELOPMENT INSTITUTE, INC.
2001
WO2000052053ANTIBODIES AGAINST PHOSPHOMANNAN THAT ARE PROTECTIVE AGAINST CANDIDIASISLIGOCYTE PHARMACEUTICALS, INC.
THE RESEARCH AND DEVELOPMENT INSTITUTE, INC.
2000
WO2000030670EFFECTS OF GDNF AND NGF ON SODIUM CHANNELS IN DRG NEURONSYALE UNIVERSITY
2000
WO2000020460METHODS FOR PRODUCING HUMAN TUMOR ANTIGEN SPECIFIC ANTIBODIESLUDWIG INSTITUTE FOR CANCER RESEARCH
2000
WO2000020594TSG-5: A TNF-INDUCIBLE GENELUDWIG INSTITUTE FOR CANCER RESEARCH
2000
WO2000018940PLANTS AND PLANTS CELLS ENCODING THE WILD TYPE COP1 GENE AND THE COIL DOMAIN THEREOFYALE UNIVERSITY
2000
WO2000015176TREATMENT OF CARCINOMAS USING SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS OR MODALITIESMAGAININ PHARMACEUTICALS INC.
2000
WO2000011942IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUEGENE LOGIC, INC.
2000
WO2000009137AMINOSTEROL COMPOUNDS AND USES THEREOFMAGAININ PHARMACEUTICALS INC.
2000
WO2000007631EXPRESSION AND CHARACTERIZATION OF HIV-1 ENVELOPE PROTEIN ASSOCIATED WITH A BROADLY REACTIVE NEUTRALIZING ANTIBODY RESPONSETHE HENRY M. JACKSON FOUNDATION
2000
WO2000008137TRANSGENIC ANIMALS HAVING A MODIFIED GLYCOPROTEIN V GENECOR THERAPEUTICS, INC.
2000
WO2000008173IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF A NOVEL RIBOSOMAL S6 PROTEIN KINASELUDWIG INSTITUTE FOR CANCER RESEARCH
2000
WO2000006141USE OF XANTHOPHYLL TO ACCENTUATE THE EFFECTS OF ESTROGENTHE BOARD OF REGENTS OF THE UNIVERSITY AND COMMUNITY COLLEGE SYSTEM OF NEVADA ON BEHALF OF THE UNIVERSITY OF NEVADA-RENO
2000
WO2000001808IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS)THE RESEARCH AND DEVELOPMENT INSTITUTE, INC.
2000
WO2000001809TAXOL PRODUCTION VIA GENERATION OF EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS)THE RESEARCH AND DEVELOPMENT INSTITUTE, INC.
2000
WO1999065931NON-ENZYMATIC CHEMICAL AMIDATION PROCESSMAGAININ PHARMACEUTICALS INC.
1999
WO1999059574A METHOD FOR STIMULATION OF DEFENSIN PRODUCTION BY EXPOSURE TO ISOLEUCINMAGAININ PHARMACEUTICALS INC.
1999
WO1999059614MODULATION OF ANGIOGENESIS AND WOUND HEALINGYALE UNIVERSITY
1999
WO1999060024METHODS FOR AMYLOID REMOVAL USING ANTI-AMYLOID ANTIBODIESTHE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION
1999
WO1999060110STABLE ENVELOPE PROTEINS FOR RETROVIRAL, VIRAL AND LIPOSOME VECTORS AND USE IN GENE AND DRUG THERAPYTHE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION
1999
WO1999057130A PROCESS TO STUDY CHANGES IN GENE EXPRESSION IN T LYMPHOCYTESGENE LOGIC, INC.
1999